Institutional investors purchased a net $1.1 million shares of ALIM during the quarter ended December 2015 and now own 49.42% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 2.0 Thousand shares of Alimera Sciences Inc
LIVINGSTON GROUP ASSET MANAGEMEN... Bought 100.00 shares of Alimera Sciences Inc
BNP PARIBAS ARBITRAGE SNC Sold 3.5 Thousand shares of Alimera Sciences Inc